BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Drug Development

  Celgene International Sárl Release: Results from a Comparative Analysis Shows REVLIMID® Demonstrates Statistically Significant Reduction in Risk of Death and No Evidence of Increased Risk of Progression to AML in Patients with Deletion 5q MDS Compared wit

  December 12, 2011

   · 

  1 min read
• Lone Star Bio

  bioTheranostics’ Breast Cancer Index(SM) Shows Clinical Utility in Late Recurrence Prognosis and Identification of Patients Eligible for Breast Conserving Surgery

  December 12, 2011

   · 

  3 min read
• Business

  Rainbow BioSciences, LLC Signs Letter of Intent with Cutting-Edge Biosciences Firm

  December 12, 2011

   · 

  1 min read
• Policy

  ETView Medical, Ltd. Announced Filing of a 510(k) Pre-Marketing Notification Application with the FDA for the VIVASIGHT™ DL Line of Innovative Airway Management Devices

  December 12, 2011

   · 

  1 min read
• Genetown

  InVivo Therapeutics Corporation Co-Founder Dr. Robert S. Langer Awarded Annual Innovation Award from The Economist

  December 12, 2011

   · 

  1 min read
• Drug Development

  Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR® for the Treatment of Heart Failure

  December 12, 2011

   · 

  5 min read
• Business

  Zyngenia Promotes Chief Scientific Officer and Hires Chief Business Officer

  December 12, 2011

   · 

  3 min read
• Silence Therapeutics plc Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents

  December 12, 2011

   · 

  5 min read
• Drug Development

  Soligenix Announces Publication of Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD

  December 12, 2011

   · 

  8 min read
• Business

  PDL BioPharma, Inc. Announces Departure of Chief Financial Officer

  December 12, 2011

   · 

  1 min read